Valacyclovir neurotoxicity: clinical experience and review of the literature
β Scribed by T. Asahi; M. Tsutsui; M. Wakasugi; D. Tange; C. Takahashi; K. Tokui; S. Okazawa; H. Okudera
- Book ID
- 111065862
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 68 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1351-5101
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. Primary sinonasal malignant melanoma (SNMM) is a rare clinical entity. There is neither a classification nor a staging system nor an evidenceβbased treatment concept established. Our objective was to find potential risk factors predicting the outcome. ## Methods. Twent
## Abstract ## BACKGROUND. Bortezomib is active in heavily pretreated multiple myeloma patients; the doseβlimiting toxicity is peripheral neuropathy (PN). ## METHODS. The authors retrospectively reviewed the incidence, severity, and risk factors for PN in 78 patients who received bortezomib. The